See who's funding clinical research across Europe – and where they're headed
Track sponsor activity by therapeutic area, geography, and trial volume. Understand the competitive landscape before your next move.
- Discover which sponsors dominate your therapeutic area
- Track where competitors are running trials – and where they're not
- Identify sponsors entering new markets or indications
- All data verified from European clinical trial registries
Know who to approach before they approach you
Stop waiting for sponsors to find you. See which companies are actively investing in your therapeutic area – and position your site ahead of the competition.
Find sponsors before the RFP
See who's running trials in your speciality – and reach out before site selection begins.
Spot where the money is going
Identify therapeutic areas with growing sponsor investment and align your site's capabilities accordingly.
See who's expanding into your region
Track sponsors entering new countries – they'll need local sites with proven expertise.
Find sponsors who need what you offer
Not all sponsors work with large vendor networks. Some are underserved – and looking for partners who can move fast.
Target sponsors with smaller vendor footprints
Identify companies running trials with fewer service partners – less competition, more opportunity.
Understand who's investing where
See which sponsors are scaling up in specific therapeutic areas – and align your pitch to their priorities.
Anticipate market moves
Track geographic expansion patterns and position your services in regions sponsors are entering.
See what your competitors see – and what they don't
The same data that helps others find you also reveals where your competitors are moving. Use it to benchmark, anticipate, and stay ahead.
Benchmark your pipeline visibility
Understand how your trial activity compares to competitors in the same therapeutic space.
Find the white space
Identify countries or indications where competitor presence is thin — potential first-mover advantage.
Track emerging players
Spot new sponsors entering your therapeutic area before they become serious competition.
Sponsor Entry & Exit Trends
Who's entering the market — and who's pulling back? (Last 12 months)
Therapeutic Area Distribution
Where is sponsor investment concentrated?
Neoplasms benign, malignant and unspecified (incl cysts and polyps) accounts for 23.6% of all sponsor activity — each sponsor counted once, in the area it runs the most trials in.
Start with who's already active
Browse sponsors running clinical trials across Europe. Filter by what matters: therapeutic focus, country presence, trial volume.
The directory shows you the landscape. A custom report gives you the strategy.
Our team can pull together sponsor intelligence tailored to your exact question – whether it's competitive positioning, market entry, or partnership opportunities. Example reports
No commitment. Describe your question – we'll tell you what's possible.